Comparative Efficacy of Tapentadol versus Tapentadol Plus Duloxetine in Patients with Chemotherapy-Induced Peripheral Neuropathy (CIPN): A Randomized Non-Inferiority Clinical Trial

Comparative Efficacy of Tapentadol versus Tapentadol Plus Duloxetine in Patients with Chemotherapy-Induced Peripheral Neuropathy (CIPN): A Randomized Non-Inferiority Clinical Trial

Introduction: Chemotherapy-induced peripheral neuropathy (CIPN) is a common complication due to treatment with many commonly used anti-cancer agents. CIPN is a mainly sensory neuropathy that can be characterized by the appearance of motor and autonomic alterations. Clinicians may offer duloxetine (D...

Full description

Bibliographic Details
Main Authors: Pasquale Sansone, Luca Gregorio Giaccari, Caterina Aurilio, Francesco Coppolino, Maria Beatrice Passavanti, Vincenzo Pota, Maria Caterina Pace
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Cancers
Subjects:
chemotherapy-induced peripheral neuropathy
duloxetine
tapentadol
Online Access:https://www.mdpi.com/2072-6694/14/16/4002

Internet

https://www.mdpi.com/2072-6694/14/16/4002

Similar Items